Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of July 2014, with the report dated July 8, 2014. The filing serves to disclose the release of an updated investor presentation and to announce the rescheduling of the Company's 2014 Annual Meeting of Shareholders.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of corporate events rather than a financial statement.
Material Changes
No material financial changes are reported in this document. The primary operational update is the adjournment of the Annual Meeting originally scheduled for July 7, 2014, due to a lack of quorum.
Outlook, Risks, and Corporate Events
- Investor Presentation: An updated investor presentation was made available on July 7, 2014, and is attached as Exhibit 99.1.
- Annual Meeting Reschedule: The 2014 Annual Meeting of Shareholders was reconvened for Monday, July 14, 2014, at 10:00 am Israel time.
- Location: The meeting will be held at the Company's offices at 10 Bareket Street, Petach Tikva, Israel.
Key Facts for Investor Verification
- Verify the content of the updated investor presentation (Exhibit 99.1) for any new strategic or financial guidance.
- Confirm the outcome of the reconvened Annual Meeting scheduled for July 14, 2014.
- Note that this filing contains no audited financial data; refer to the most recent Form 20-F for financial metrics.